Men with an intellectual disability face significant inequalities throughout the entire prostate cancer care pathway, study ...
Chimeric antigen receptor (CAR)-T cells — immune cells that have been modified to express an artificial receptor that enables them to recognize and attack tumours — are already used to treat blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results